510(k) K892856
K892856 is an FDA 510(k) premarket notification submitted by Acacia Laboratories, Inc. for the device "NEWMARK(TM) CORONARY ARTERY BYPASS GRAFT MARKERS". The FDA issued a decision of Substantially Equivalent on Nov 8, 1989. The device falls under product code KRI (Accessory Equipment, Cardiopulmonary Bypass), a Class I device regulated under 21 CFR 870.4200. Acacia Laboratories, Inc. has 11 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Nov 8, 1989
- Date Received
- Apr 18, 1989
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Accessory Equipment, Cardiopulmonary Bypass
- Device Class
- Class I
- Regulation Number
- 870.4200
- Review Panel
- CV
- Submission Type
- 510(k) Exempt
Need the full FDA record for Acacia Laboratories, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.